Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Hiromitsu Yokota"'
Autor:
Ichiro Tatsuno, Naomi Shimizu, Youichi Iwashita, Hiromitsu Yokota, Hidekazu Hasunuma, Yasuhiro Watanabe, Yasuo Matsuzawa
Publikováno v:
Internal Medicine
Oxidative stress is closely related to iron overload in myelodysplastic syndrome (MDS) and induces DNA damage. We evaluated the oxidative stress markers derivatives of reactive oxidative metabolites (dROM) and 8-hydroxy-2'-deoxyguanosine (8-OHdG) dur
Autor:
Shunsuke Nakagawa, Kazuhiro Nakamura, Hitoshi Ikeda, Junken Aoki, Ryunosuke Ohkawa, Hiromitsu Yokota, Akiko Masuda, Tetsu Yano, Koji Igarashi, Yutaka Yatomi
Publikováno v:
Lipids. 47:927-930
Autotaxin (ATX) is a glycoprotein that was first identified in the conditioned medium of human melanoma cells as an autocrine motility factor. It possesses lysophospholipase D activity, producing the bioactive lipid mediator lysophosphatidic acid (LP
Autor:
Yukiko Tanaka, N Itou, Kazuoki Osumi, Takafumi Fukui, H Satoh, Masaru Okabe, H Hirai, Kiyoshi Kitamura, Kazuhiko Nakahara, Hiromitsu Yokota, N H Tsuno
Publikováno v:
Leukemia. 16:1167-1175
Using a real-time RT-PCR method, we analyzed the expression of e1a2 BCR-ABL mRNA in bone marrow samples from 13 patients with e1a2 BCR-ABL-positive acute lymphoblastic leukemia (ALL) at different time points during chemotherapy and after bone marrow
Autor:
Mineo Kurokawa, Keiki Kumano, Naoko Watanabe-Okochi, Tomohiko Sato, Hiromitsu Yokota, Toshiyuki Ikeda, Akihide Yoshimi, Yumiko Satoh, Jiro Kitaura, Toshio Kitamura, Yutaka Yatomi, Koki Takahashi, Akihito Shinohara, Kazuki Taoka, Akiko Masuda, Takako Tsuruta
Publikováno v:
Scopus-Elsevier
Ecotropic viral integration site 1 (Evi1) is one of the master regulators in the development of acute myeloid leukemia (AML) and myelodysplastic syndrome. High expression of Evi1 is found in 10% of patients with AML and indicates a poor outcome. Seve
Autor:
Hirokazu Nagawa, Yumiko Satoh, Daiya Takai, Yutaka Yatomi, Joji Kitayama, Kazuhiko Mori, Hiroshi Uozaki, Kentaro Kitano, Yasuhiro Seto, Hiroki Sasaki, Hiromitsu Yokota, Masashi Fukayama
Publikováno v:
Japanese journal of clinical oncology. 42(2)
Prediction of peritoneal recurrence in gastric cancer patients is important for application of adjuvant chemotherapy. After surgery, occasional patients have peritoneal recurrence despite negative cytology of the peritoneal washings. Thus, molecular
Autor:
Masahiro Jona, Yumiko Satoh, Yutaka Yatomi, Mineo Kurokawa, Akiko Masuda, Hiromitsu Yokota, Yasuhito Nannya
Publikováno v:
European Journal of Haematology. 92:456-457
Autor:
Ryunosuke Ohkawa, Tatsuya Kishimoto, Yasushi Kozai, Hitoshi Ikeda, Hiromitsu Yokota, Yukako Koike, Koji Igarashi, Junken Aoki, Akiko Masuda, Mineo Kurokawa, Shinichi Okudaira, Katsumi Higashi, Kazuhiro Nakamura, Masahiro Jona, Yutaka Yatomi, Koji Izutsu, Takuro Watanabe
Publikováno v:
British journal of haematology. 143(1)
Autotaxin (ATX) is a tumour cell motility-stimulating factor originally isolated from melanoma cell supernatants. ATX is identical to lysophospholipase D, which produces a bioactive lipid mediator, lysophosphatidic acid (LPA), from lysophosphatidylch
Autor:
Hitoshi Ikeda, Minoru Tozuka, Hiroyuki Arai, Kazuhiro Nakamura, Takumi Takeuchi, Hiromitsu Yokota, Ryunosuke Ohkawa, Noriko Ohshima, Yutaka Yatomi, Shigeo Okubo, Tadaichi Kitamura, Junken Aoki
Publikováno v:
Annals of clinical biochemistry. 44(Pt 6)
Background: It is now established that the bioactive lipid lysophosphatidic acid (LPA) contributes to cancer initiation, progression and metastasis, including those of prostate cancer. LPA is produced in the serum and plasma mainly by conversion from
Autor:
Mineo Kurokawa, Toru Motokura, Motoshi Ichikawa, Hiromitsu Yokota, Shigeru Chiba, Tsuyoshi Takahashi, Yutaka Yatomi, Kumi Oshima, Hiroyuki Sato, Akira Hangaishi, Sumimasa Nagai, Yoshinobu Kanda, Koji Izutsu
Publikováno v:
Experimental hematology. 35(11)
Objective Systemic mastocytosis with associated clonal hematological non–mast cell lineage disease (SM-AHNMD) is a distinct entity that was defined by World Health Organization. Systemic mastocytosis with acute myeloid leukemia (AML) is frequently
Publikováno v:
European Journal of Haematology. 73:307-308